Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: Evidence for a hyperplastic vasculomyopathy

Genetics in Medicine

Volumn 12, Issue 4, 2010, Pages 196-203

  Milewicz, Dianna M ^a   Kwartler, Callie S ^a   Papke, Christina L ^a   Regalado, Ellen S ^a   Cao, Jiumei ^a   Reid, Amy J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

ACTA2; Aneurysm; Arterial occlusion; Arterial stenosis; Hyperplastic vasculomyopathy; Moyamoya; Neurofibromatosis; NF1 neurofibromin; Proliferation; Smooth muscle cells; Smooth muscle actin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; IMATINIB; MUTANT PROTEIN; NEUROFIBROMIN;

ANEURYSM; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ATHEROSCLEROSIS; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; GENE MUTATION; GENE TARGETING; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HYPERPLASIA; MOYAMOYA DISEASE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ACTINS; ADULT; CELL PROLIFERATION; CORONARY VESSELS; HUMANS; HYPERPLASIA; MUTATION; MYOCYTES, SMOOTH MUSCLE; NEUROFIBROMIN 1; VASCULAR DISEASES;

EID: 77951478759     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181cdd687     Document Type: Review

References (55)

1. Fauci AS, Kasper DL, Longo DL, et al., editors. Harrison's principles of internal medicine, 17th ed. New York: McGraw-Hill, 2008.
2. Topol EJ, Smith J, Plow EF, Wang QK. Genetic susceptibility to myo-cardial infarction and coronary artery disease. Hum Mol Genet 2006;15: R117-R123. (Pubitemid 44446784)
3. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512-1531.
4. Roy H, Bhardwaj S, Yla-Herttuala S. Molecular genetics of atherosclerosis. Hum Genet 2009;125:467-491.
5. Wang Q. Molecular genetics of coronary artery disease. Curr Opin Cardiol 2005;20:182-188. (Pubitemid 40704874)
6. Kudo T. Spontaneous occlusion of the circle of Willis. A disease apparently confined to Japanese. Neurology 1968;18:485-496.
7. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99(suppl 2):S238-S240.
8. Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children\a scientific statement from a special writing group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the young. Stroke 2008;39:2644-2691.
9. Haltia M, Iivanainen M, Majuri H, Puranen M. Spontaneous occlusion of the circle of Willis (Moyamoya Syndrome). Clin Neuropathol 1982;1:11-22. (Pubitemid 13128107)
10. Masuda J, Ogata J, Yutani C. Smooth-muscle cell-proliferation and localization of macrophages and T-cells in the occlusive intracranial major arteries in Moyamoya disease. Stroke 1993;24:1960-1967. (Pubitemid 23352730)
11. Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K. Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 1996;27:1750-1754. (Pubitemid 26332498)
12. Ikeda E. Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke 1991;22:1358-1362.
13. Goldberg HJ. Moyamoya associated with peripheral vascular occlusive disease. Arch Dis Childhood 1974;49:964-966.
14. Mineharu Y, Liu W, Inoue K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 2008;70:2357-2363.
15. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000;15:179-182. (Pubitemid 30202245)
16. Nanba R, Tada M, Kuroda S, Houkin K, Iwasaki Y. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease. Childs Nerv Syst 2005;21:62-68.
17. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999;64:533-537. (Pubitemid 129500535)
18. Sakurai K, Horiuchi Y, Ikeda H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004;49:278-281. (Pubitemid 38856021)
19. Friedman JM, Arbiser J, Epstein JA, et al. Cardiovascular disease in neu-rofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet Med 2002;4:105-111. (Pubitemid 44698568)
20. Spengos K, Kosmaidou-Aravidou Z, Tsivgoulis G, Vassilopoulou S, Grigori-Kostaraki P, Zis V. Moyamoya syndrome in a Caucasian woman with Turner's syndrome. Eur J Neurol 2006;13:e7-e8. (Pubitemid 44434307)
21. Gaba RC, Shah RP, Muskovitz AA, Guzman G, Michals EA. Synchronous moyamoya syndrome and ruptured cerebral aneurysm in Alagille syndrome. J Clin Neurosci 2008;15:1395-1398.
22. Imaizumi M, Nukada T, Yoneda S, Takano T, Hasegawa K, Abe H. Tuberous sclerosis with moyamoya disease. Case report. Med J Osaka Univ 1978;28:345-353. (Pubitemid 9028730)
23. Schuster JM, Roberts TS. Symptomatic moyamoya disease and aortic co-arctation in a patient with Noonan's syndrome: strategies for management. Pediatr Neurosurg 1999;30:206-210.
24. Kawai M, Nishikawa T, Tanaka M, et al. An autopsied case of Williams syndrome complicated by moyamoya disease. Acta Paediatr Jpn 1993;35: 63-67. (Pubitemid 23107267)
25. Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 2007;87:521-544. (Pubitemid 47086282)
26. Strohman RC, Paterson B, Fluck R, Przybyla A. Cell fusion and terminal differentiation of myogenic cells in culture. J Anim Sci 1974;38:1103-1110.
27. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801. (Pubitemid 38823766)
28. Brisset AC, Hao H, Camenzind E, et al. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 2007;100:1055-1062. (Pubitemid 46598930)
29. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995;75:487-517.
30. Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev 2009;89:957-989.
31. Karnik SK, Brooke BS, Bayes-Genis A, et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003;130: 411-423. (Pubitemid 36175937)
32. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007;27:1248-1258. (Pubitemid 46809412)
33. Hirschi KK, Majesky MW. Smooth muscle stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004;276:22-33.
34. Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM. Fate of the mammalian cardiac neural crest. Development 2000;127:1607-1616. (Pubitemid 30234918)
35. Stoller JZ, Epstein JA. Cardiac neural crest. Semin Cell Dev Biol 2005;16: 704-715.
36. Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 2005;64:553-555. (Pubitemid 40189883)
37. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986;314:1010-1015. (Pubitemid 16113061)
38. Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 2001;68:1110-1118. (Pubitemid 32424410)
39. Chew DK, Muto PM, Gordon JK, Straceski AJ, Donaldson MC. Spontaneous aortic dissection and rupture in a patient with neurofibromatosis. J Vasc Surg 2001;34:364-366. (Pubitemid 33661139)
40. Oderich GS, Sullivan TM, Bower TC, et al. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg 2007;46:475-484.
41. Dasgupta B, GutmannDH. Neurofibromatosis 1: closing the GAP between mice and men. Curr Opin Genet Dev 2003;13:20-27. (Pubitemid 36143923)
42. Hamilton SJ, Friedman JM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet 2000;58:341-344.
43. Stewart DR, Cogan JD, Kramer MR, et al. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy? Chest 2007;132:798-808.
44. Li F, Munchhof AM, White HA, et al. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. Hum Mol Genet 2006;15:1921-1930. (Pubitemid 43821782)
45. Xu J, Ismat FA, Wang T, Yang J, Epstein JA. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response. Circulation 2007;116:2148-2156. (Pubitemid 350060352)
46. Lasater EA, Bessler WK, Mead LE, et al. Nf1 +/-mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway. Hum Mol Genet 2008;17:2336-2344.
47. Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007;68:932-938. (Pubitemid 46568506)
48. Guo DC, Pannu H, Papke CL, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 2007;39:1488-1493. (Pubitemid 350191352)
49. Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alphaactin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009;84: 617-627.
50. Schildmeyer LA, Braun R, Taffet G, et al. Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J 2000;14:2213-2220.
51. Takeji M, Moriyama T, Oseto S, et al. Smooth muscle alpha-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis. J Biol Chem 2006;281:40193-40200. (Pubitemid 46041824)
52. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 2005;85:9-23. (Pubitemid 40128037)
53. Li DY, Brooke B, Davis EC, Mecham RP, et al. Elastin is an essential determinant of arterial morphogenesis. Nature 1998;393:276-280. (Pubitemid 28261728)
54. Milewicz DM, Guo D, Tran-Fadulu V, et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 2008;9:283-302.
55. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 2003;300:329-332. (Pubitemid 36433724)